CHAJO Eye Care (02219) intends to repurchase company shares worth up to 50 million Hong Kong dollars.

CHAOJU EYE CARE (02219) announces that on November 17, 2025, the board of directors has resolved to conduct share repurchases on the open market up to a total value of HKD 50 million starting from November 17, 2025. This decision is in accordance with the share repurchase authorization approved by the company's shareholders at the annual general meeting held on June 6, 2025, and any subsequent updates or renewals approved by shareholders. The company believes that the share repurchase will demonstrate its confidence in its business outlook and prospects, ultimately benefiting the company and creating value for its shareholders. Depending on market conditions, the board of directors may increase the maximum purchase amount under the share repurchase authorization from time to time. If the board decides to increase the maximum repurchase amount, the company will make timely announcements in accordance with listing rules. The board believes that the company's current financial resources are sufficient to implement share repurchases while maintaining a healthy financial position.